CRAC intermediate 2

• Description:

  CRAC intermediate 2 (the starting compound in example 23) is an intermediate. CRAC intermediate 2 can be used in the research of CRAC inhibitors[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  CRAC Channel; Drug Intermediate

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel; Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/CRAC-intermediate-2.html

• Purity:

  99.45

• Solubility:

  DMSO : ≥ 52 mg/mL

• Smiles:

  NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1

• Molecular Formula:

  C11H7F6N3

• Molecular Weight:

  295.18

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Cao, et al. Compounds that modulate intracellular calcium. WO2013059666A1. WIPO (PCT) . 2012-10-19.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [123066-64-8]